(19)
(11) EP 4 798 232 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24883194.3

(22) Date of filing: 22.10.2024
(51) International Patent Classification (IPC): 
A61K 39/02(2006.01)
A61K 39/385(2006.01)
A61P 31/04(2006.01)
C07K 14/25(2006.01)
A61K 38/04(2006.01)
C07H 21/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 31/04; C07K 14/25; A61K 2039/54; A61K 2039/545; A61K 39/0283; A61K 2039/575; A61K 2239/39; A61K 2039/55594; Y02A 50/30
(86) International application number:
PCT/US2024/052421
(87) International publication number:
WO 2025/090513 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 24.10.2023 US 202363545473 P

(71) Applicants:
  • VAXCYTE, INC.
    San Carlos, California 94070 (US)
  • University Of Maryland, Baltimore
    Baltimore, Maryland 21201 (US)

(72) Inventors:
  • FAIRMAN, Jeff
    San Carlos, California 94070 (US)
  • KAPOOR, Neeraj
    San Carlos, California 94070 (US)
  • TAMILSELVI, Chitradevi Sekar
    Baltimore, Maryland 21201 (US)
  • TAREKEGN, Girmay Desalegn
    Baltimore, Maryland 21201 (US)
  • PASETTI, Marcela F.
    Baltimore, Maryland 21201 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) SHIGELLA VACCINE COMPOSITIONS